Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Search Results to Arthur M Krieg MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Krieg, Arthur

Item TypeName
Concept Disease Models, Animal
Concept Lung Neoplasms
Concept Prostatic Neoplasms
Concept Models, Immunological
Concept Neoplasms, Experimental
Concept Cancer Vaccines
Concept Models, Biological
Concept Liver Neoplasms
Concept Thyroid Neoplasms
Concept Models, Animal
Concept Kidney Neoplasms
Concept Models, Molecular
Concept Neoplasms
Concept Skin Neoplasms
Concept Colonic Neoplasms
Academic Article Early development of the Toll-like receptor 9 agonist, PF-3512676, for the treatment of patients with advanced cancers.
Academic Article Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
Academic Article Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909.
Academic Article Development of TLR9 agonists for cancer therapy.
Academic Article Antitumor mechanisms of oligodeoxynucleotides with CpG and polyG motifs in murine prostate cancer cells: decrease of NF-kappaB and AP-1 binding activities and induction of apoptosis.
Academic Article Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.
Academic Article CpG oligonucleotides enhance the tumor antigen-specific immune response of a granulocyte macrophage colony-stimulating factor-based vaccine strategy in neuroblastoma.
Academic Article CpG oligodeoxynucleotides augment the murine immune response to the Yersinia pestis F1-V vaccine in bubonic and pneumonic models of plague.
Academic Article The ability of CpG oligonucleotides to protect mice against Francisella tularensis live vaccine strain but not fully virulent F. tularensis subspecies holarctica is reflected in cell-based assays.
Academic Article Paradoxical enhancement of CD8 T cell-dependent anti-tumor protection despite reduced CD8 T cell responses with addition of a TLR9 agonist to a tumor vaccine.
Academic Article Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself.
Academic Article [Stem cell-induced liver regeneration].
Academic Article TRAIL-beta and TRAIL-gamma: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential.
Academic Article Phase I trial of toll-like receptor 9 agonist PF-3512676 with and following rituximab in patients with recurrent indolent and aggressive non Hodgkin's lymphoma.
Academic Article CpG oligonucleotides protect against Venezuelan equine encephalitis virus infection in a route-dependent manner.
Academic Article Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.
Academic Article CpG still rocks! Update on an accidental drug.
Academic Article CpG motifs in bacterial DNA and their immune effects.
Academic Article Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Academic Article CpG-DNA protects against a lethal orthopoxvirus infection in a murine model.
Academic Article PD-1 and Tim-3 regulate the expansion of tumor antigen-specific CD8? T cells induced by melanoma vaccines.
Academic Article CpG oligodeoxynucleotides potentiate the antitumor effects of chemotherapy or tumor resection in an orthotopic murine model of rhabdomyosarcoma.
Academic Article CpG oligodeoxynucleotides do not require TH1 cytokines to prevent eosinophilic airway inflammation in a murine model of asthma.
Academic Article The role of CpG motifs in innate immunity.
Academic Article Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.
Academic Article CpG oligonucleotides enhance the tumor antigen-specific immune response of an anti-idiotype antibody-based vaccine strategy in CEA transgenic mice.
Academic Article Immunostimulatory CpG oligonucleotides enhance the immune response of anti-idiotype vaccine that mimics carcinoembryonic antigen.
Academic Article Interdisciplinary treatment of primary hepatic angiosarcoma: emergency tumor embolization followed by elective surgery.
Academic Article Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.
Academic Article Toll-like receptor 9 (TLR9) agonists in the treatment of cancer.
Academic Article Cancer and inflammation: promise for biologic therapy.
Academic Article Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides.
Academic Article Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.
Academic Article Therapeutic potential of Toll-like receptor 9 activation.
Academic Article Randomized phase II trial of a toll-like receptor 9 agonist oligodeoxynucleotide, PF-3512676, in combination with first-line taxane plus platinum chemotherapy for advanced-stage non-small-cell lung cancer.
Academic Article Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse.
Academic Article CpG oligonucleotides as immune adjuvants.
Academic Article Sensitivity to TRAIL/APO-2L-mediated apoptosis in human renal cell carcinomas and its enhancement by topotecan.
Academic Article Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Academic Article New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site.
Academic Article Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
Academic Article Decreased cytotoxic T cell activity generated by co-administration of PSA vaccine and CpG ODN is associated with increased tumor protection in a mouse model of prostate cancer.
Academic Article Immunization with analog peptide in combination with CpG and montanide expands tumor antigen-specific CD8+ T cells in melanoma patients.
Academic Article From bugs to drugs: therapeutic immunomodulation with oligodeoxynucleotides containing CpG sequences from bacterial DNA.
Academic Article Structure-activity relationship studies on the immune stimulatory effects of base-modified CpG toll-like receptor 9 agonists.
Academic Article Dendritic cells pulsed or fused with AML cellular antigen provide comparable in vivo antitumor protective responses.
Academic Article Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.
Academic Article CpG oligodeoxynucleotide enhances tumor response to radiation.
Academic Article Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.
Academic Article Retroviruses and autoimmunity.
Academic Article CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide.

Search Criteria
  • orthotopic
  • cancer
  • models